IP Library Granted Patent US 10,500,220
Granted Patent B2
US 10,500,220 · App. 16/209,542 · Granted Dec 10, 2019

Topical compositions

Inventors: Ryan Doxey (Raleigh, NC); Nathan Stasko (Chapel Hill, NC)
Assignee: Novan, Inc.
A61K31/695A61K8/34A61K8/345A61K8/368A61K8/40A61K8/585A61K8/731A61K8/891A61K9/0014A61K47/10A61K47/20A61K47/34A61K47/38A61Q19/00A61K9/143A61K2800/22A61K2800/31A61K2800/56A61K2800/592
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,500,220
App. No.
16/209,542
Granted
Dec 10, 2019
Kind
B2
Abstract

Provided herein are anhydrous compositions that include at least one viscosity increasing agent, at least one organic solvent and at least one humectant. Such compositions may also include at least one active pharmaceutical ingredient (API) and/or at least one water repellant. Related compositions, methods and kits are also provided.

Claims (42)

1. A method of decreasing abnormal keratinization, reducing microbial colonization, reducing inflammation and/or decreasing sebum production in a subject in need thereof, the method comprising applying an anhydrous composition to the skin of a subject to treat the dermatological condition,

wherein the anhydrous composition consists essentially of:

hydroxypropyl cellulose at a concentration in a range of 0.5% to about 2% by weight of the anhydrous composition,

ethanol or isopropyl alcohol at a concentration in a range of 45% to 90% by weight of the anhydrous composition,

hexylene glycol at a concentration of about 10% by weight of the anhydrous composition,

cyclomethicone at a concentration of about 2.5% by weight of the anhydrous composition, and

a nitric oxide (NO)-releasing compound at a concentration in a range of 0.01% to 40% by weight of the anhydrous composition,

wherein the method decreases abnormal keratinization, microbial colonization, inflammation, and/or sebum production in the skin of the subject.

2. The method of claim 1 , wherein the subject has acne and the method comprises treating the acne.

3. The method of claim 1 , wherein the anhydrous composition comprises ethanol.

4. The method of claim 1 , wherein the anhydrous composition comprises isopropyl alcohol.

5. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration in a range of 0.01% to 30% by weight of the anhydrous composition.

6. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration in a range of 0.01% to 2% by weight of the anhydrous composition.

7. The method of claim 1 , wherein the hydroxypropyl cellulose is present in the anhydrous composition at a concentration in a range of 0.5% to about 1% by weight of the anhydrous composition.

8. The method of claim 1 , wherein the hydroxypropyl cellulose is present in the anhydrous composition at a concentration of about 1% by weight of the anhydrous composition.

9. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 1% by weight of the anhydrous composition.

10. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 2% by weight of the anhydrous composition.

11. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 4% by weight of the anhydrous composition.

12. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 8% by weight of the anhydrous composition.

13. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 12% by weight of the anhydrous composition.

14. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 16% by weight of the anhydrous composition.

15. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 20% by weight of the anhydrous composition.

16. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 24% by weight of the anhydrous composition.

17. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 30% by weight of the anhydrous composition.

18. The method of claim 1 , wherein the NO-releasing compound is present in the anhydrous composition at a concentration of about 32% by weight of the anhydrous composition.

19. The method of claim 1 , wherein the NO-releasing compound comprises diazeniumdiolated co-condensed silica particles.

20. The method of claim 1 , wherein the method decreases abnormal keratinization in the skin of the subject.

21. The method of claim 1 , wherein the method decreases microbial colonization in the skin of the subject.

22. The method of claim 1 , wherein the method decreases inflammation in the skin of the subject.

23. The method of claim 1 , wherein the method decreases sebum production in the skin of the subject.

24. A method of treating a dermatological condition, the method comprising applying an anhydrous composition to the skin of a subject to treat the dermatological condition,

wherein the anhydrous composition consists essentially of:

hydroxypropyl cellulose at a concentration in a range of 0.5% to about 2% by weight of the anhydrous composition,

ethanol or isopropyl alcohol at a concentration in a range of 45% to 90% by weight of the anhydrous composition,

hexylene glycol at a concentration of about 10% by weight of the anhydrous composition,

cyclomethicone at a concentration of about 2.5% by weight of the anhydrous composition, and

a nitric oxide (NO)-releasing compound at a concentration in a range of 0.01% to 40% by weight of the anhydrous composition,

wherein the dermatological condition comprises acne, a scar, a wound, and/or a biofilm.

25. The method of claim 24 , wherein the dermatological condition comprises acne.

26. The method of claim 24 , wherein the dermatological condition comprises a scar.

27. The method of claim 24 , wherein the dermatological condition comprises a wound.

28. The method of claim 24 , wherein the dermatological condition comprises a biofilm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2025
From: LNHC, INC.
To: LIGAND PHARMACEUTICALS INCORPORATED
Reel/Frame 071481/0040 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2024
From: NOVAN, INC.
To: LNHC, INC.
Reel/Frame 066350/0942 →
Cited By (2)
US 12,403,087 US 12,503,428